The Glomerulonephritis Pipeline Market Review, H1 2017 is a new market research report introducing the Company Profiles involved in the therapeutics development and the Drug Profiles management by stages and target of molecules. The Glomerulonephritis Pipeline Market Report covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages and enlists all their major and minor projects.
Glomerulonephritis is also known as glomerular nephritis (GN) or glomerular disease. It is a disease of the kidney, characterized by inflammation of the glomeruli. Causes of glomerulonephritis include Streptococcal infection of the throat known as strep throat, immune diseases, such as lupus, Type 1 diabetes and type 2 diabetes and viruses, such as HIV, hepatitis B virus, and hepatitis C virus. Factors that increase chances of getting glomerulonephritis include family history of glomerulonephritis, the presence of a known cause of glomerulonephritis and high blood pressure. Common symptoms of glomerulonephritis are blood in the urine (dark, rust-colored, or brown urine), foamy urine, swelling (edema) of the face, eyes, ankles, feet, legs, or abdomen. Treatment will depend on the cause of glomerulonephritis such as medications, lifestyle changes, dialysis and transplant.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=983973 .
Pharmaceutical and Healthcare latest pipeline guide Glomerulonephritis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Glomerulonephritis (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The latest Pharmaceutical and Healthcare disease pipeline guide Glomerulonephritis - Pipeline Review, H1 2017, provides an overview of the Glomerulonephritis (Genito Urinary System and Sex Hormones) pipeline landscape.
The Key Company Profiles are Achillion Pharmaceuticals Inc, Alexion Pharmaceuticals Inc, Anthera Pharmaceuticals Inc, Biogen Inc, BLR Bio LLC, ChemoCentryx Inc, Dimerix Bioscience Pty Ltd, GlaxoSmithKline Plc, Mallinckrodt Plc, Omeros Corp, Pfizer Inc, Pharmalink AB, Ra Pharmaceuticals Inc, Retrophin Inc, Rigel Pharmaceuticals Inc, Shire Plc and Visterra Inc.
Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=983973
Glomerulonephritis (Genito Urinary System and Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Glomerulonephritis (Genito Urinary System and Sex Hormones).
The pipeline guide reviews pipeline therapeutics for Glomerulonephritis (Genito Urinary System and Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Glomerulonephritis (Genito Urinary System and Sex Hormones) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Glomerulonephritis (Genito Urinary System and Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Glomerulonephritis (Genito Urinary System and Sex Hormones)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=983973 .
Table of Contents:
Glomerulonephritis - Overview
Glomerulonephritis - Therapeutics Development
Glomerulonephritis Pipeline Overview
Glomerulonephritis Pipeline by Companies
Glomerulonephritis Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Glomerulonephritis - Therapeutics Assessment
Glomerulonephritis - Companies Involved in Therapeutics Development
Glomerulonephritis - Drug Profiles
Glomerulonephritis - Dormant Projects
Glomerulonephritis - Product Development Milestones

List of Tables.
Number of Products under Development for Glomerulonephritis, H1 2017
Glomerulonephritis Products under Development by Companies, H1 2017
Glomerulonephritis Number of Products by Stage and Molecule Type, H1 2017
Glomerulonephritis - Pipeline by ChemoCentryx Inc
Glomerulonephritis - Pipeline by Visterra Inc
Glomerulonephritis - Pipeline by Pharmalink AB
Glomerulonephritis - Pipeline by Pfizer Inc
Glomerulonephritis - Dormant Projects, H1 2017
Glomerulonephritis - Discontinued Products, H1 2017

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.